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Abstract
Helicobacter pylori is one of the most prevalent causes of gastritis. This pathogen 
colonizes for many years human stomach and asymptomatically leads the persons 
to chronic gastritis. The eradication of H. pylori from human stomach is, therefore, 
important in order to prevent the digestive diseases including peptic ulcers and 
gastric cancer that develop via chronic atrophic gastritis. Wide-spectrum antibiot-
ics such as amoxicillin and metronidazole are used for the treatment for H. pylori 
infectious diseases. However, the H. pylori strains resistant to these antibiotics are 
increasing year by year around the world. On this basis, we need urgently to develop 
the antibacterial medicines that act on H. pylori with a novel mechanism. Recent 
studies by our group have demonstrated that H. pylori shows susceptibility to the 
bactericidal action of indene compounds derived from decomposition of vitamin D. 
The bactericidal action of indene compounds is selective not against commonplace 
bacteria but against H. pylori. The indene compounds turned out to target the  
H. pylori’s phosphatidylethanolamine that retains a myristic acid as the saturated 
fatty acid side chain. These findings will contribute to the development of new anti-
bacterial medicines specialized to the treatment for H. pylori infectious diseases.
Keywords: Helicobacter pylori, phosphatidylethanolamine, myristic acid, vitamin D, 
indene compound
1. Introduction
Helicobacter pylori is a Gram-negative microaerophilic helical bacillus equipped 
with polar flagella as the motility organ. This bacterium colonizes human stom-
ach and causes chronic atrophic gastritis [1]. In addition to gastritis, the patients 
infected with this pathogen are capable of having various digestive diseases such as 
gastric ulcer, duodenal ulcer, gastric mucosa-associated lymphoid tissue (MALT) 
lymphoma, and gastric cancer [2–7]. Therefore, the eradication of H. pylori from 
human stomach is aggressively carried out around the world. Wide-spectrum 
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antibiotics such as amoxicillin, metronidazole, and clarithromycin are used for the 
treatment for H. pylori infectious diseases. However, the H. pylori strains resistant to 
the wide-spectrum antibiotics have been increasing year after year [8]. Especially, 
almost all H. pylori strains clinically isolated from African people have been acquir-
ing the resistance to amoxicillin and metronidazole. In addition, wide-spectrum 
antibiotics act not only on H. pylori but also on commonplace bacteria inhabiting 
the mucosa of mouth and intestines. Therefore, the patients infected with H. pylori, 
who orally take wide-spectrum antibiotics for the treatment, often suffer from side 
effects such as stomatitis, constipation, and loose bowels resulted from the collapse 
of the balance of either oral bacterial flora or enterobacterial flora. When the side 
effects are serious, the patients develop pseudomembranous colitis accompanied 
with bloody feces and are compelled to discontinue the eradication of H. pylori [9]. 
To solve the difficult problems on the chemotherapy, we have to develop a novel 
antibacterial medicine that acts on only H. pylori without affecting the survival of 
human mucosal bacterial flora.
The assimilation of exogenous cholesterol into the cell membranes is one of the 
unique biological features of H. pylori. A part of cholesterol assimilated into the cell 
membranes is modified with a α-glucose at the carbon position-3 of its steroid frame-
work, and the cholesteryl glucosides generated are used as the bacterial cell membrane 
constituents [10]. A previous study by our group has revealed that H. pylori possesses 
at least three types of cholesteryl glucosides, cholesteryl-α-D-glucopyranoside (CGL), 
cholesteryl-6-O-tetradecanoyl-α-D-glucopyranoside (CAG), and cholesteryl-6-O-
phosphatidyl-α-D-glucopyranoside (CPG) (Figure 1) [11]. In addition to the three 
cholesteryl glucosides, other researchers have identified the lyso-type of CPG [12]. 
CGL is synthesized by the catalytic action of cholesterol α-glucosyltransferase (CGT) 
that localizes to the cytoplasm-side of the inner membrane of H. pylori [13–15]. CGT 
transfers a glucose derived from a uridine diphosphate glucose (UDP-Glc) to the 
cholesterol. Although the enzyme proteins involved in the synthesis of either CAG or 
CPG remain to be clarified, a recent study by other group has demonstrated that the 
enzymatic activities for the synthesis of CAG and CPG are detected in H. pylori’s outer 
membrane and inner membrane, respectively [16]. In addition, both enzymatic activi-
ties for the synthesis of CAG and CPG turned out to use phosphatidylethanolamine 
(PE) as the substrate [16]. In sum, the CGL acyltransferase (CGLAT) transfers a fatty 
acid derived from PE to the CGL and thereby synthesizes CAG. Meanwhile, the CGL 
phosphatidyltransferase (CGLPT) transfers a phosphatidyl group derived from PE to 
the CGL and thereby synthesizes CPG.
Figure 1. 
Chemical structures of cholesteryl glucosides found in H. pylori cell membranes. In addition to the three 
types of cholesteryl glucosides, H. pylori possesses the lyso-type of CPG that dissociated a myristic acid. CGL, 
cholesteryl-α-D-glucopyranoside; CAG, cholesteryl-6-O-tetradecanoyl-α-D-glucopyranoside; CPG, cholesteryl-
6-O-phosphatidyl-α-D-glucopyranoside; C14, myristic acid; C19, phytomonic acid.
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A number of studies, including our own, have revealed that H. pylori assimilates 
exogenous cholesterol in order to acquire the resistance to the antibacterial actions of 
antibiotics and lipophilic compounds [17–20]. Meanwhile, H. pylori glucosylates the 
assimilated cholesterol to evade the host immune systems and/or to detoxify the toxic 
steroid compounds with 3β-hydroxyl [12, 21]. The mechanism as for cholesterol uptake 
of H. pylori, however, remained for many years to be clarified. In a study in 2012, it has 
been revealed that PE of H. pylori cell membranes functions as a cholesterol-binding 
lipid [22]. PE is the most predominant glycerophospholipid component composing 
Gram-negative bacterial cell membranes. The PE of Gram-negative bacteria such as 
Enterobacteriaceae bacteria and Pseudomonas aeruginosa retains a palmitic acid (C16:0) 
as the saturated fatty acid side chain, whereas the PE of H. pylori retains a myristic 
acid (C14:0) as the saturated fatty acid side chain [22–26]. In sum, the PE molecular 
species composition of H. pylori turned out to completely differ from that of typical 
Gram-negative bacteria. A previous study by our group has demonstrated that the PE 
accounts for greater than 60% in the total lipids (excluding lipopolysaccharide) of  
H. pylori in the logarithmic growth phase [27]. Moreover, it has been revealed that the 
PE molecular species (DMPE) with two myristic acids accounts for approximately 
30% in the total PE molecular species of H. pylori [22]. Intriguingly, DMPE showed 
higher binding affinity for cholesterol than for cholesteryl ester (Figure 2). In sum, 
the selective intermolecular interaction was found between the low-molecular-weight 
hydrophobic compounds.
Based on a number of studies including our own, the overview from the choles-
terol assimilation to the cholesterol glucosylation was partially clarified in  
H. pylori: (1) cholesterol binds at least to DMPE of the outer membrane of H. pylori 
and is assimilated into the membranes; (2) a part of cholesterol is glucosylated by 
the catalytic action of CGT localized to the cytoplasm-side of the inner membrane, 
and thereby CGL is generated; (3) CGL is next exchanged to CAG and CPG by 
the enzymatic actions of CGLAT and CGLPT that localize to the outer membrane 
and the inner membrane, respectively (Figure 3). CGT utilizes an UDP-Glc as 
the glucose donor of cholesterol. Both enzymes of CGLAT and CGLPT utilize PE 
(myristoyl-PE) as the acyl group donor and phosphatidyl group donor of CGL, 
Figure 2. 
Binding affinity of dimyristoyl-phosphatidylethanolamine of H. pylori cell membranes for either cholesterol 
or cholesteryl ester. Dipalmitoyl-PE with two palmitic acids (C16:0) shows the high binding affinity for both of 
cholesterol and cholesteryl ester, whereas dimyristoyl-PE (DMPE) with two myristic acids (C14:0) shows the 
selective high binding affinity only for cholesterol.
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respectively. Incidentally, cholesterol assimilated into H. pylori is distributed to both 
of the inner and outer membranes, whereas cholesteryl glucosides (CGL, CAG, and 
CPG) synthesized by H. pylori predominantly localize to the outer membrane [17].
As described above, it has been revealed that DMPE is one of the most prevalent 
lipid components of H. pylori cell membranes and shows the unique interaction 
not with cholesteryl ester but with cholesterol. Apart from this, previous studies 
by our group have demonstrated that a steroid hormone, progesterone acts on the 
cholesterol-binding site in the H. pylori cell membranes and confers the bactericidal 
action to H. pylori [28, 29]. Although it was unclear as for whether the progesterone 
shows the selective binding affinity for DMPE, this steroid turned out to destabilize 
the cell membrane structure of H. pylori and to ultimately induce the bacteriolysis. 
These findings drove us to the investigations of the low-molecular-weight hydro-
phobic compounds that induce the serious structure change to the DMPE molecule 
through the specific interaction. This chapter mentions the bactericidal activity of 
the indene compounds against H. pylori.
2. Development of new antibacterial medicines for H. pylori
2.1 Finding of an indene compound as the anti-H. pylori substance
The anti-H. pylori activity of various steroidal compounds was investigated. As a 
consequence, 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of secosteroids 
turned out to confer the strong bacteriolytic action to H. pylori [30]. However, 
these vitamin D3 derivatives conspicuously attenuated their bactericidal activity 
by the nonbiological degradation (Table 1). In contrast, H. pylori did not almost 
Figure 3. 
Cholesteryl glucoside synthesis and its enzyme localization in H. pylori cell membranes. CGT, cholesterol 
α-glucosyltransferase; CGLAT, CGL acyltransferase; CGLPT, CGL phosphatidyltransferase; Cho, cholesterol; 
MPE, myristoyl phosphatidylethanolamine; LPS, lipopolysaccharide; UDP-Glc, uridine diphosphate-glucose.
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succumb to the bacteriolytic action of vitamin D3. Surprisingly, the nonbiological 
degradation of vitamin D3 augmented the bactericidal activity of its secosteroid 
against H. pylori. These results indicated that the vitamin D3 derivatives directly act 
as bactericidal substances on H. pylori, and that some decomposition product of 
vitamin D3 possesses potent bactericidal activity against H. pylori. It was, therefore, 
attempted to extract the anti-H. pylori substance from the decomposition products 
of vitamin D3. As a consequence, the indene compound species (VDP1), otherwise 
known as Grundmann’s ketone, was successfully obtained [31, 32]. VDP1 is a low-
molecular-weight hydrophobic compound in which the indene consisting of 5- and 
6-membered rings of hydrocarbons was modified with alkyl, carbonyl, and methyl 
(Figure 4). Intriguingly, H. pylori showed high susceptibility to the bacteriolytic 
action of VDP1, whereas commonplace bacteria such as Enterobacteriaceae bacteria, 
P. aeruginosa, and Staphylococcus aureus showed insusceptibility to that of VDP1 
[30]. In addition, VDP1 conferred the effective bacteriolytic action to H. pylori 
regardless of the assimilation of cholesterol into the cell membranes. These results 
indicate the possibility that VDP1 is a beneficial fundamental structure for the 
development of antibacterial medicines to selectively eradicate H. pylori without 
collapsing the balance of human mucosal bacterial flora.
2.2 Interaction between VDP1 and PE molecular species
The collapse induction activity of VDP1 against lipid vesicles was next examined 
using the unilamellar vesicles prepared with DMPE, dipalmitoyl-PE (DPPE), and 
dioleoyl-PE (DOPE). Intriguingly, VDP1 turned out to specifically induce the struc-
ture collapse of DMPE unilamellar vesicles without affecting the structural stability 
of either DPPE unilamellar vesicles or DOPE unilamellar vesicles (Figure 5). The 
structure collapse induction activity of VDP1 against DMPE unilamellar vesicles 
completely corresponded to the bactericidal activity of the indene compound 
Table 1. 
Bacteriolytic action of vitamin D3 and its derivatives against H. pylori.
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against H. pylori that abundantly contains DMPE in the cell membranes. Based 
on these results, VDP1 was considered to specifically interact with the DMPE, to 
induce the serious structure change to the myristic acid side chain in the PE mol-
ecule, and to ultimately disrupt the vesicular conformation of DMPE. In addition, 
these results strongly suggested that VDP1 exerts the bactericidal effect on H. pylori 
by targeting at least DMPE of the cell membranes.
The intermolecular interaction between VDP1, DMPE, and DPPE was, there-
fore, simulated by the computational chemistry. One of the computer simulations 
showed that VDP1 induces “the winding-structure change” to a myristic acid side 
chain in DMPE molecule, while VDP1 induced no structure change to a palmitic 
acid side chain in DPPE molecule (Figure 5). The alkyl of VDP1 seemed to be 
crucial conformation for the induction of the structure change of the myristic acid 
side chain of DMPE. In other words, the slight difference of the length of carbon 
Figure 4. 
Bacteriolytic action of VDP1 against H. pylori. H. pylori shows high susceptibility to bacteriolytic action of 
VDP1 derived from decomposition of vitamin D3. Meanwhile, commonplace bacteria such as Escherichia coli 
and Staphylococcus aureus show insusceptibility to bacteriolytic action of VDP1. VDP1, (1R,3aR,7aR)-1-
[(1R)-1,5-dimethylhexyl]octahydro-7a-methyl-4H-inden-4-one.
Figure 5. 
Specific intermolecular interaction between VDP1 and DMPE. Dye-containing unilamellar vesicles were 
prepared with DMPE, dipalmitoyl-PE (DPPE) or dioleoyl-PE (DOPE) and incubated for 5 minutes in the 
presence or absence of VDP1. The absorbance (A590 nm) of dye released from the PE unilamellar vesicles was 
measured (left graph). The data were obtained from the three independent experiments and are denoted 
with the mean A590 nm ± standard deviation. Statistical significance (P < 0.05) was calculated by the Student’s 
t-test. N.S. denotes “no statistical significance.” VDP1 induces the selective conformation change to the DMPE 
unilamellar vesicles. The intermolecular interactions between VDP1 and PE molecular species were simulated 
by the computational chemistry (right panel). VDP1 induces the conformational change only to a myristic acid 
side chain in the PE molecule without affecting the conformational stability of a palmitic acid side chain in the 
PE molecule.
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chain composing the fatty acids in PE molecules appeared to play an important role 
on the specific interaction between VDP1 and PE molecular species.
2.3 Bactericidal mechanism of the indene compound species
As described earlier, VDP1 was considered to confer the bacteriolytic action 
to H. pylori by the disruption of the cell membranes through the induction of 
the structure change of DMPE that is one of the most prevalent PE molecular 
species constructing the bacterial cell membranes. To investigate in detail the 
crucial conformation of VDP1 for exerting the structure collapse effect on DMPE 
unilamellar vesicles and for exerting the antibacterial effect on H. pylori, various 
VDP1 derivatives were chemically synthesized [33]. The structure collapse induc-
tion activity of VDP1 against DMPE unilamellar vesicles was already ascertained to 
almost completely correspond to the bactericidal activity of the indene compound 
against H. pylori. When the carbonyl of VDP1 was replaced with a hydroxyl, the 
indene compound (VD3-1) maintained both activities against DMPE unilamellar 
vesicles and H. pylori (Table 2). As seen in VDP1, VD3-1 turned out to confer no 
structure collapse induction activity against DPPE unilamellar vesicles. In addi-
tion, VD3-1 also had no influence on the viability of commonplace bacteria such 
as Enterobacteriaceae bacteria, P. aeruginosa, and S. aureus. Intriguingly, VD2-2 that 
lacks the alkyl chain of VD3-1 was ascertained to induce no structure collapses of 
either DMPE unilamellar vesicles or DPPE unilamellar vesicles and to completely 
forfeit the effective bactericidal activity against H. pylori. In combination with the 
result of computer simulation as for the intermolecular interaction between VDP1 
and DMPE, these results indicate that the alkyl structure in the indene compound 
*Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Serratia marcescens, Salmonella sp., Pseudomonas 
aeruginosa, and Staphylococcus aureus. VD3-1, (1R,3aR,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)octahydro-
1H-inden-4-ol; VD2-2, (1R,3aR,7aR)-1-((S)-1-hydroxypropan-2-yl)-7a-methyloctahydro-1H-inden-4-ol.
Table 2. 
Relationship between indene compounds, PE unilamellar vesicles and H. pylori.
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species plays a crucial role on the induction of the structure change of the myristic 
acid side chain in DMPE molecule. Moreover, the alkyl structure in the indene 
compound species turned out to be essential for exerting the effective bacteriolytic 
action to H. pylori. The functional groups such as carbonyl and hydroxyl of the 
indene compound species seem to be significant conformation for bonding to the 
phosphate head in the PE molecules with an electrostatic attraction. Meanwhile, 
the indene-ring structure is guessed to be significant to stabilize the hydrophobic 
interaction between the indene compound species and PE molecules.
A recent study by our group has demonstrated that VDP1 confers the anti-
bacterial action not only to H. pylori but also to other Helicobacter species [33]. 
Especially, Helicobacter felis showed high susceptibility to the bacteriolytic action 
of VDP1, as similar to H. pylori. H. felis is a Gram-negative microaerophilic spiral 
bacillus possessing bipolar tufts of flagella. This bacterium is isolated from the 
gastric mucosa of cats and dogs [34–36]. As seen in H. pylori, H. felis causes chronic 
gastritis and gastric MALT lymphoma in mouse when it colonizes the mouse 
stomach [37, 38]. An earlier study by our group has revealed that a myristic acid 
accounts for approximately 16% in the fatty acid composition of H. felis PE, and 
that the PE molecular species retaining a myristic acid and a palmitic acid accounts 
for approximately 37% in total PE molecular species of the bacteria [39]. Though 
H. felis completely succumbs to the bacteriolytic action at the same concentration 
of VDP1 (less than 3 μg/ml) that eradicates H. pylori, this Helicobacter species did 
not possess DMPE. On this basis, VDP1 is considered to interact not only with 
DMPE but also with myristoyl-PE that retains a myristic acid as one of the two fatty 
acid side chains. In addition, H. felis turned out to possess lauryl-PE as the most 
prevalent PE molecular species. The PE molecular species retaining a lauric acid 
(C12:0) and a palmitic acid accounted for approximately 40% in total PE molecular 
species of H. felis. In sum, large parts of PE molecular species of H. felis bind a 
palmitic acid and either a myristic acid or a lauric acid as the fatty acid side chains. 
Given that a lauric acid is shorter in the length of carbon chain than a myristic acid, 
we can assume that VDP1 collapses the vesicular conformation consisting not only 
of myristoyl-PE but also of lauryl-PE. In the future, it will need to elucidate the 
hydrophobic interaction between VDP1 and lauryl-PE in addition to myristoyl-PE.
In contrast, Helicobacter cinaedi showed low susceptibility to the bacteriolytic 
action of VDP1, even though the PE molecular species composition in H. cinaedi 
is similar to the PE molecular species composition in H. felis [39]. H. cinaedi is a 
Gram-negative rod-like bacillus equipped with bipolar flagella and isolated from 
the intestinal tracts and livers of various mammals such as human, dog, cat, and 
hamster [40–42]. Therefore, this bacterium is classified into the enterohepatic 
Helicobacter species [43, 44]. Meanwhile, H. pylori and H. felis are classified into 
the gastric Helicobacter species. Most of the persons infected with H. cinaedi have 
no clinical symptoms, but some persons suffer from systematic inflammations, 
namely phlegmone, arthritis, and meningitis, due to the bacteremia [45]. Although 
it is unclear as for why H. cinaedi is lower in the VDP1-susceptibility than the two 
Helicobacter species, the involvement of lipopolysaccharide (LPS) is considered as 
one possibility. LPS is a glycolipid constructed of a long polysaccharide chain and 
fatty acids and is one of the composition components of the outermost layer of the 
outer membrane of Gram-negative bacteria [46]. The part of polysaccharide chain 
in LPS comes into direct contact with the outsides of the bacterial cells and limits 
the membrane permeability of various lipophilic compounds. The LPS contents in 
H. cinaedi may be higher than those in H. pylori and H. felis. The membrane perme-
ability of VDP1 through the LPS barrier may be, therefore, stricter in H. cinaedi 
than in H. pylori and H. felis. Further investigation will be necessary to compare the 
LPS contents between the Helicobacter species.
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Based on the current studies, the following bactericidal mechanism of the 
indene compounds synthetically derived from vitamin D in H. pylori was proposed: 
the indene compounds bind to the myristoyl-PE (including DMPE) of H. pylori cell 
membranes, induce “the winding-structure change” to the myristic acid side chain 
Figure 6. 
A proposed bactericidal mechanism of the indene compound species for H. pylori. The indene compound species 
such as VDP1 and VD3-1 bind to the myristoyl-PE of H. pylori cell membranes and induce “the winding-
structure change” to the myristic acid side chain of the especially DMPE. H. pylori ultimately lyses via the 
destabilization of the membrane conformation.
Figure 7. 
Role of cholesterol and cholesteryl glucosides in H. pylori. Cholesterol (Cho) binds to the myristoyl-PE (MPE) 
including dimyristoyl-PE (DMPE) of the H. pylori’s cell membranes but has no influence on the stability of the 
cell membrane conformation. As similar to cholesterol, no cholesteryl glucosides (CGL, CAG, and CPG) affect 
the cell membrane stability of H. pylori. These steroidal compounds are assimilated as the membrane lipid 
constituents of H. pylori and serve to strengthen the cell membrane lipid barrier. Incidentally, VDP1 confers the 
bacteriolytic action to H. pylori regardless of the cholesterol assimilation into the cell membranes.
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in the PE molecules, destabilize the membrane conformation, and ultimately confer 
the bacteriolytic action to H. pylori (Figure 6).
In the case of the cholesterol assimilation in H. pylori, cholesterol is distributed 
to both membranes of the outer membrane and the inner membrane, and a part of 
the cholesterol is, thereafter, metabolized to cholesteryl glucosides (CGL, CAG, and 
CPG), and these metabolites localize to the outer membrane (Figure 7). Cholesterol 
and cholesteryl glucosides have no influence on the stability of the cell mem-
brane conformation of H. pylori, and rather these steroidal compounds serve to 
strengthen the membrane lipid barrier of the bacteria on the limitation of the per-
meability of lipophilic compounds. A recent study by other group has demonstrated 
that cholesteryl glucosides are responsible for the morphological maintenance of  
H. pylori, for the acquirement of resistance to antibiotics such as polymyxin B, 
colistin, and tetracycline, and for the promotion of biofilm formation [47]. This 
suggests that cholesteryl glucosides of H. pylori play an important role to limit the 
membrane permeability of various low-molecular-weight compounds. However, 
VDP1 confers the bacteriolytic action even to H. pylori retaining cholesterol and 
cholesteryl glucosides. Further investigation will be necessary to clarify the detailed 
intermolecular interactions between myristoyl-PE and steroidal compounds.
3. Conclusions
Almost all hydrophobic drugs are pharmacologically designed to inhibit the 
functions of either protein molecules or nucleic acids in the target creature species. 
However, no drugs that target a characteristic lipid molecule in the creatures are 
discovered for many years. In addition, a number of biochemists on lipid research 
leave great achievements in the analysis of biosynthetic enzymes of various lipo-
philic compounds such as fatty acids and complex lipids and in the identification of 
receptors of various hydrophobic ligands such as steroid hormones and eicosanoids. 
However, these achievements are not as for lipid itself but as for merely proteins. 
This chapter described the unique interaction between lipids: the indene compound 
species specifically disrupt the vesicular conformation consisting of DMPE. These 
findings will bring the new aspects to the drug discovery research and the lipid 
biochemistry research.
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